Is Systane (polyethylene glycol/propylene glycol) used to treat dry eye?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, Systane is Used for Dry Eye Treatment

Systane (polyethylene glycol/propylene glycol) is FDA-approved and clinically indicated for the temporary relief of burning and irritation due to dryness of the eye, and represents a first-line treatment option for dry eye disease. 1

Clinical Evidence and Positioning

According to the 2024 American Academy of Ophthalmology Dry Eye Syndrome Preferred Practice Pattern, artificial tears are the foundational treatment for mild dry eye disease 2. Systane functions as an artificial tear substitute that provides aqueous enhancement to the ocular surface, which is the appropriate initial therapeutic approach as dry eye severity increases 2.

Treatment Algorithm Based on Severity

For Mild Dry Eye:

  • Start with artificial tears like Systane
  • Use preserved formulations if applying ≤4 times daily
  • Switch to preservative-free formulations (like Systane Complete MDPF) when using more than 4 times daily 2
  • Address environmental factors (humidity, air drafts, screen positioning)

For Moderate to Severe Dry Eye:

  • Continue artificial tears as baseline therapy
  • Add anti-inflammatory agents (cyclosporine 0.05%, lifitegrast 5%) 2
  • Consider punctal occlusion or other advanced interventions 2

Specific Systane Formulation Evidence

The propylene glycol-hydroxypropyl guar (PG-HPG) nanoemulsion formulation (Systane Complete) demonstrates superior performance compared to standard lubricants:

  • Significantly greater reduction in OSDI scores (-9.9 points vs -4.13 points with comparable products, p=0.05) 3
  • Greater reduction in corneal staining (-2.8 vs -0.9, p<0.001) 3
  • Improved tear film stability, lipid layer thickness, and meibomian gland function 4, 5

A 2014 comparative trial showed Systane Gel Drops produced significantly better corneal staining improvement versus carboxymethylcellulose-based drops (-3.4 vs -2.5 units, p=0.0294) 6.

Key Clinical Considerations

Preservative Status Matters:

  • Preserved formulations are acceptable for infrequent use (≤4 times daily) in patients with healthy ocular surfaces 2
  • Chronic or frequent use (>4 times daily) requires preservative-free formulations to avoid toxicity 2
  • Systane Complete MDPF (multi-dose preservative-free) addresses this requirement 3, 7

Mechanism of Action:

  • Propylene glycol (0.3-0.6%) acts as the demulcent/lubricant 1, 8
  • Hydroxypropyl guar forms a cross-linked gel matrix with tear film borate ions, prolonging retention 8
  • Phospholipid components replenish the lipid layer, addressing evaporative dry eye 8, 5

Common Pitfalls to Avoid

  1. Don't use preserved formulations chronically - this can worsen ocular surface disease through preservative toxicity
  2. Don't rely solely on artificial tears for moderate-severe disease - these patients require anti-inflammatory therapy in addition to lubrication 2
  3. Don't ignore underlying causes - treat concurrent blepharitis, meibomian gland dysfunction, or systemic conditions 2

Safety Profile

Systane demonstrates excellent safety with no significant adverse events reported in multiple clinical trials 3, 4, 5, 9. The formulation is well-tolerated with minimal ocular burning compared to other dry eye treatments 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.